These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 17828603)

  • 1. Reproducibility and reliability of tumor grading in urological neoplasms.
    Engers R
    World J Urol; 2007 Dec; 25(6):595-605. PubMed ID: 17828603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Updates in Histologic Grading of Urologic Neoplasms.
    Rice-Stitt T; Valencia-Guerrero A; Cornejo KM; Wu CL
    Arch Pathol Lab Med; 2020 Mar; 144(3):335-343. PubMed ID: 32101058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Grading systems in renal cell carcinoma.
    Novara G; Martignoni G; Artibani W; Ficarra V
    J Urol; 2007 Feb; 177(2):430-6. PubMed ID: 17222604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraobserver and interobserver variability of Fuhrman and modified Fuhrman grading systems for conventional renal cell carcinoma.
    Bektas S; Bahadir B; Kandemir NO; Barut F; Gul AE; Ozdamar SO
    Kaohsiung J Med Sci; 2009 Nov; 25(11):596-600. PubMed ID: 19858038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Reproducibility of Fuhrman nuclear grade: advantages of a two-grade system].
    Letourneux H; Lindner V; Lang H; Massfelder T; Meyer N; Saussine C; Jacqmin D
    Prog Urol; 2006 Jun; 16(3):281-5. PubMed ID: 16821337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interobserver reproducibility of a grading system for chromophobe renal cell carcinoma.
    Pérez-Pedrosa A; Ortiz-Rey JA; Lorenzo-Mahía Y; Iglesias-Rodríguez B; Peteiro-Cancelo A; González-Carreró J
    Actas Urol Esp; 2013 Jun; 37(6):338-41. PubMed ID: 23058995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of Histological Grading Systems in Veterinary Medicine.
    Avallone G; Rasotto R; Chambers JK; Miller AD; Behling-Kelly E; Monti P; Berlato D; Valenti P; Roccabianca P
    Vet Pathol; 2021 Sep; 58(5):809-828. PubMed ID: 33769136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Grading and prognostic significance of urologic carcinomas.
    Helpap B
    Urol Int; 1992; 48(3):245-57. PubMed ID: 1589911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder.
    Bol MG; Baak JP; Buhr-Wildhagen S; Kruse AJ; Kjellevold KH; Janssen EA; Mestad O; Øgreid P
    J Urol; 2003 Apr; 169(4):1291-4. PubMed ID: 12629345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histologic grading of urothelial papillary neoplasms: impact of combined grading (two-numbered grading system) on reproducibility.
    Tuna B; Yörükoglu K; Düzcan E; Sen S; Nese N; Sarsık B; Akder A; Sayhan S; Mungan U; Kirkali Z
    Virchows Arch; 2011 Jun; 458(6):659-64. PubMed ID: 21484429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 388 patients with conventional renal cell carcinoma.
    Ficarra V; Martignoni G; Maffei N; Brunelli M; Novara G; Zanolla L; Pea M; Artibani W
    Cancer; 2005 Jan; 103(1):68-75. PubMed ID: 15573369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The WHO/ISUP grading system for renal carcinoma].
    Moch H
    Pathologe; 2016 Jul; 37(4):355-60. PubMed ID: 27271258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interobserver reproducibility of Gleason grading of prostatic carcinoma: urologic pathologists.
    Allsbrook WC; Mangold KA; Johnson MH; Lane RB; Lane CG; Amin MB; Bostwick DG; Humphrey PA; Jones EC; Reuter VE; Sakr W; Sesterhenn IA; Troncoso P; Wheeler TM; Epstein JI
    Hum Pathol; 2001 Jan; 32(1):74-80. PubMed ID: 11172298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter determination of optimal interobserver agreement using the Fuhrman grading system for renal cell carcinoma: Assessment of 241 patients with > 15-year follow-up.
    Lang H; Lindner V; de Fromont M; Molinié V; Letourneux H; Meyer N; Martin M; Jacqmin D
    Cancer; 2005 Feb; 103(3):625-9. PubMed ID: 15611969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of coagulation factors in urological malignancy: A prospective, controlled study on prostate, renal and bladder cancer.
    Alevizopoulos A; Tyritzis S; Leotsakos I; Anastasopoulou I; Pournaras C; Kotsis P; Katsarou O; Alamanis C; Stravodimos K; Constantinides C
    Int J Urol; 2017 Feb; 24(2):130-136. PubMed ID: 28004432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interobserver variability in Gleason histological grading of prostate cancer.
    Ozkan TA; Eruyar AT; Cebeci OO; Memik O; Ozcan L; Kuskonmaz I
    Scand J Urol; 2016 Dec; 50(6):420-424. PubMed ID: 27416104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathological advances in renal, prostatic, bladder and testis neoplasia].
    Rioux-Leclercq N; Comperat E; Kammerer-Jacquet SF; Camparo P; Fromont G;
    Prog Urol; 2016 Jun; 26(8):477-83. PubMed ID: 27473787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative light microscopy in urological oncology.
    van der Poel HG; Schaafsma HE; Vooijs GP; Debruyne FM; Schalken JA
    J Urol; 1992 Jul; 148(1):1-13. PubMed ID: 1613843
    [No Abstract]   [Full Text] [Related]  

  • 19. Interobserver reproducibility of Gleason grading of prostatic carcinoma: general pathologist.
    Allsbrook WC; Mangold KA; Johnson MH; Lane RB; Lane CG; Epstein JI
    Hum Pathol; 2001 Jan; 32(1):81-8. PubMed ID: 11172299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudopapillary features in prostatic adenocarcinoma mimicking urothelial carcinoma: a diagnostic pitfall.
    Gordetsky J; Epstein JI
    Am J Surg Pathol; 2014 Jul; 38(7):941-5. PubMed ID: 24503758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.